superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2022-03-31
- Valid until
- 2022-06-30
- Published
- 2022-04-28
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 2,419,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Amgen total equity: 916,000,000 United States dollar", as of 2022-03-31 (until 2022-06-30). Claim clm_68A37D10302E, https://asof.is/claim/clm_68A37D10302E, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815422000021/0000318154-22-000021-index.htm.
APA
AsOf. (2022). Amgen total equity: 916,000,000 United States dollar (as of 2022-03-31 (until 2022-06-30)) [Record clm_68A37D10302E]. Retrieved November 8, 2026, from https://asof.is/claim/clm_68A37D10302E (source: https://www.sec.gov/Archives/edgar/data/318154/000031815422000021/0000318154-22-000021-index.htm)
BibTeX
@misc{asof_clm_68A37D10302E,
author = {AsOf},
title = {Amgen total equity: 916,000,000 United States dollar},
year = {2022},
howpublished = {\url{https://asof.is/claim/clm_68A37D10302E}},
note = {Claim clm\_68A37D10302E, as of 2022-03-31 (until 2022-06-30); source: https://www.sec.gov/Archives/edgar/data/318154/000031815422000021/0000318154-22-000021-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_68A37D10302E.md/v1/claims/clm_68A37D10302Esubmit a correction